Savana cNLP (EHRead)
Multilingual clinical NLP trained on 7B+ EHR documents for regulatory-grade extraction
Company profile
Company profile
Savana is a healthtech SaaS company specializing in scientifically validated, multilingual clinical natural language processing (NLP) trained exclusively on electronic health records. The company's proprietary EHRead engine processes over seven billion clinical documents across seven languages to extract regulatory-grade real-world evidence from unstructured clinical narratives. Savana's ecosystem includes the Manager Suite for structuring hospital EHR data, Data Space for federated cross-institutional collaboration, and Next-Generation Registries (NGR) for continuous evidence generation. The company also operates the Smart Health Alliance, a global federated network of hospitals across Europe, North America, and Latin America enabling multicentre, multilingual research. Savana's technology addresses a critical gap in real-world evidence generation: most RWE pipelines rely on structured fields like diagnosis codes and lab values, missing the rich clinical context documented in free-text notes where disease activity, treatment response, and adverse events are actually recorded. By extracting from discharge summaries, consultation reports, and clinical narratives, Savana enables hospitals to improve care pathways and accelerate research, while providing life sciences companies with always-on, regulatory-grade evidence supporting R&D, market access, and post-marketing strategies. The platform ensures GDPR, HIPAA, and EHDS compliance through its DeID Station, maintains source traceability for regulatory audits, and supports evidence generation that meets FDA, EMA, and HTA body requirements.
Company description Saranas official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Api Only · Cloud Saas deployment with recorded integration context.
Company milestones
Multiple peer-reviewed publications in 2026, expansion of Smart Health Alliance global network, development of AI-powered living registries (NGR), EHDS-ready Data Space deployment
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Multilingual clinical NLP trained on 7B+ EHR documents for regulatory-grade extraction
Federated, EHDS-ready health data space for secure cross-institutional collaboration
Multilingual de-identification engine ensuring GDPR, HIPAA, and EHDS compliance
Hospital-native clinical data platform structuring EHR data for analytics and research
AI-powered next-generation registries for regulatory-grade evidence generation
Data transformation tools for clinical research pipelines
Tool for managing clinical variables in research workflows
Global federated hospital network for multicentre AI-driven research
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of the Society for Cardiovascular Angiography & Interventions · Jan 1, 2023
Clinical validation
No linked records are currently available.
Regulatory
K230273 · 510k · May 25, 2023
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
From unstructured EHR clinical narratives
Across multilingual EHR training corpus
Every extraction maps to source phrase for regulatory audit
Development and validation of interpretable machine learning models to detect unconfirmed hepatitis C using electronic health records
Natural Language Processing of Unstructured Healthcare Data for Predicting Heart Failure in Individuals with Type 2 Diabetes
Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data
Towards A Better Paradigm for Head and Neck Cancer Treatment Applying Artificial Intelligence
Advancing lung cancer insights: A metastatic NSCLC disease panel and NLP performance evaluation for clinical data extraction from EHRs
Assessing the real-world impact of interstitial lung disease in patients with rheumatoid arthritis on healthcare resources and treatment patterns through natural language processing
05 · Leadership
Leadership profiles and professional links from the current Company record.
Dr. Ignacio H. Medrano
Author/Clinical Expert
06 · Company updates
Recent articles published on Saranas's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.